Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00759031 · ClinicalTrials.gov registry record · Phase 3

Investigation of Dental Plaque and Gingival Index

A Phase 3 study, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
19
Enrollment target

NCT00759031 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00759031, a Phase 3 study, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
19 participants
Enrollment target

Study Summary

Investigation of inhibitory effect of prototype toothpaste on dental plaque formation via modified gingival margin plaque index method.

Interventions

  • DRUG Sodium Monofluorophosphate
  • DRUG Triclosan/Fluoride/Copolymer

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2008-02
Est. Completion 2008-03
Phase Phase 3

Sponsor

Colgate Palmolive

51 total trials

What the Registry Record Tells You About NCT00759031

The ClinicalTrials.gov registry entry for NCT00759031 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sodium Monofluorophosphate is the first listed.

NCT00759031 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00759031 about?

NCT00759031 is a clinical study titled "Investigation of Dental Plaque and Gingival Index". Investigation of inhibitory effect of prototype toothpaste on dental plaque formation via modified gingival margin plaque index method.

What is the current status of trial NCT00759031?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2008-02. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00759031?

The interventions under investigation include: Sodium Monofluorophosphate (DRUG), Triclosan/Fluoride/Copolymer (DRUG).

Who is sponsoring clinical trial NCT00759031?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.